Bayesian Capital Management’s Maxim Integrated Products MXIM Stock Holding History

Bayesian Capital Management’s Portfolio MXIM Stock Details MXIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-30,796	Closed	-$2.08M	–	715
2020 Q3	$2.08M	Buy	30,796 +18,996	+161%	+$1.29M	0.51%	39
2020 Q2	$715K	Sell	11,800 -8,200	-41%	-$457K	0.16%	185
2020 Q1	$972K	Buy	+20,000	New	+$1.15M	0.21%	137
2019 Q1	–	Sell	-11,129	Closed	-$566K	–	822
2018 Q4	$566K	Sell	11,129 -2,071	-16%	-$108K	0.12%	251
2018 Q3	$744K	Buy	13,200 +4,900	+59%	+$295K	0.12%	241
2018 Q2	$487K	Buy	+8,300	New	+$483K	0.11%	269
2018 Q1	–	Sell	-25,300	Closed	-$1.32M	–	893
2017 Q4	$1.32M	Buy	+25,300	New	+$1.31M	0.27%	116
2017 Q2	–	Sell	-17,100	Closed	-$769K	–	648
2017 Q1	$769K	Buy	+17,100	New	+$749K	0.36%	76

Other funds holding MXIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bayesian Capital Management's MXIM Position: Q4 2020 in Review

Bayesian Capital Management sold out of Maxim Integrated Products (MXIM) in Q4 2020, closing a stake of 30,796 shares — an estimated $2.08M sold.

Bayesian Capital Management first reported a position in MXIM in Q1 2017 and held it in 8 quarters. The position peaked at $2.08M in Q3 2020. 632 funds tracked by Wall St. Rank hold MXIM as of Q4 2020.

Bayesian Capital Management reported no remaining Maxim Integrated Products position as of Q4 2020 after selling out during the quarter.
Bayesian Capital Management sold 30,796 Maxim Integrated Products shares in Q4 2020, an estimated $2.08M.
Bayesian Capital Management first reported a position in Maxim Integrated Products in Q1 2017 and held it in 8 quarters.
Bayesian Capital Management's Maxim Integrated Products position peaked at $2.08M in Q3 2020.
632 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q4 2020.

Based on Bayesian Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.